User profiles for Daniela Maria Cirillo

Daniela Maria Cirillo

IRCCS San Raffaele Scientific Institute
Verified email at hsr.it
Cited by 40642

Macrophage‐dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival

DM Cirillo, RH Valdivia, DM Monack… - Molecular …, 1998 - Wiley Online Library
Salmonella pathogenicity island 2 (SPI‐2) encodes a putative type III secretion system necessary
for systemic infection in animals. We have investigated the transcriptional organization …

Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages

…, NE Ntinginya, A Rachow, M Hoelscher, DM Cirillo… - Nature …, 2016 - nature.com
Generalist and specialist species differ in the breadth of their ecological niches. Little is known
about the niche width of obligate human pathogens. Here we analyzed a global collection …

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

…, B Williams, WW Yew, JP Zellweger, DM Cirillo - 2014 - Eur Respiratory Soc
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) substantially challenges TB control, especially in the European Region of the World …

[HTML][HTML] Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

…, S Andres, AM Cabibbe, DM Cirillo… - The Lancet infectious …, 2016 - thelancet.com
Background Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new
rifampicin-sparing regimens. However, little information about the extent of resistance to …

[HTML][HTML] Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates–the EUCAST broth microdilution reference method for MIC determination

…, G Kahlmeter, C Giske, M Santin, DM Cirillo… - Clinical Microbiology …, 2020 - Elsevier
Scope Several methods are used worldwide for antibiotic susceptibility testing (AST) for the
Mycobacterium tuberculosis complex (MTBC). The variability in the results obtained with …

[HTML][HTML] The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

…, M Hunt, L Chindelevitch, MR Farhat, DM Cirillo… - The Lancet …, 2022 - thelancet.com
Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…

[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

…, JW Alffenaar, HS Schaaf, BJ Marais, DM Cirillo… - International Journal of …, 2020 - Elsevier
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

[HTML][HTML] MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates

…, V Schleusener, MR De Filippo, P Beckert, DM Cirillo… - PeerJ, 2018 - peerj.com
Analyzing whole-genome sequencing data of Mycobacterium tuberculosis complex (MTBC)
isolates in a standardized workflow enables both comprehensive antibiotic resistance …

[HTML][HTML] Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

…, A Borbe-Reyes, DP Chin, DM Cirillo… - The Lancet Infectious …, 2018 - thelancet.com
Background In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis
drugs is hampered by the limitations of phenotypic testing for drug susceptibility. …

Defining the needs for next generation assays for tuberculosis

CM Denkinger, SV Kik, DM Cirillo… - The Journal of …, 2015 - academic.oup.com
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed
urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics …